kingrollo
Guru
Enlighten me please, I don't watch the news for reasons explained in my last post.
Double the amount of people vaccinated lowers your risk more than fewer people with higher protection.
Enlighten me please, I don't watch the news for reasons explained in my last post.
Yeah it's a bit like a manufacturer who constantly produces crappy GPS units ....then suddenly they produce a decent one.... People are understandably cautious !
Double the amount of people vaccinated lowers your risk more than fewer people with higher protection.
Your GP must be struggling with the simple math's articulated by Whitty (for at least the second time) in today's briefing.![]()
Enlighten me please, I don't watch the news for reasons explained in my last post.
As well as @kingrollo 's concise answer (lowers the likely number of people becoming ill to the extent they need hospital admission).Double the amount of people vaccinated lowers your risk more than fewer people with higher protection.
I was only paying limited attention because he so bloody boring but I thought he didn't completely discount the possibility of it resulting in a vaccine resistant mutation?
Was that towards the end ? - because I didn't hear that.
Of course he can't completely discount the possibility . . . almost by definition. But he can infer from other similar viral experience that that possibility is low (or lower) in the timeframe which will make a difference. But then the media can say: "there's a possibility of it resulting in a vaccine resistant mutation", and away we go.
Lol - we have an actual Tory MP posting on here !!!! Incredible !!! - not content with the right wing press support - they are now planting spin doctors on forums.....
But then the media can say: "there's a possibility of it resulting in a vaccine resistant mutation", and away we go.
Full bmj article from which your quote is drawn (Covid-19 vaccination: What’s the evidence for extending the dosing interval?)."Could the gap lead to vaccine resistant strains of SARS-CoV-2?
Paul Bieniasz, a retrovirologist from Rockefeller University who is studying how the virus can acquire mutations, . . .